Unaudited Condensed Interim Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Net Sales	$ 3,551,564	$ 1,560,633	$ 7,748,499	$ 4,727,631
Cost of Goods Sold	2,500,163	1,482,455	5,231,155	3,825,037
Gross Profit	1,051,401	78,178	2,517,344	902,594
Operating Expenses
Research and development	0	65,037	53,408	65,037
Stock based compensation	426,268	279,707	1,102,609	381,314
Selling, General and Administrative Expenses	2,256,757	624,228	5,888,863	1,443,276
Total Operating Expenses	2,683,025	968,972	7,044,880	1,889,627
Operating Loss	(1,631,624)	(890,794)	(4,527,536)	(987,033)
Other Income (Loss)
Change in Fair Market Value	151,570	0	(148,882)	0
Forgiveness of paycheck protection program loan	296,827	0	296,827	0
Other Income	1,068	235	26,250	11,905
Total Other Income	449,465	235	174,195	11,905
Loss Before Benefit	(1,182,159)	(890,559)	(4,353,341)	(975,128)
Benefit from Income Taxes	(101,354)		(101,354)
Net Loss	(1,080,805)	(890,559)	(4,251,987)	(975,128)
Net Loss attributable to common stockholders:
Dividends to preferred shareholders	(241,500)		(241,500)
Net Loss attributable to common stockholders	$ (1,322,305)	$ (890,559)	$ (4,493,487)	$ (975,128)
Basic and Diluted Loss Per Common Share	$ (0.14)	$ (0.17)	$ (0.48)	$ (0.19)
Weighted Average Shares Outstanding - basic and diluted	9,421,908	5,222,422	9,282,675	5,075,513